1.A Study on the Sexual Adjustment and Quality of Life in Married Men with Spinal cord Injuries.
Korean Journal of Rehabilitation Nursing 2000;3(1):27-42
The purpose of this study was to identify the degree of sexual adjustment and quality of life in married men with spinal cord injuries and to furnish primary data to sexuality rehabilitation nursing practice which can lead to ideal sexual life and quality of life those men with SCl. Seventy married men with SCI were conveniently sampled in Kwangju, Suncheon, Mokpo and Seoul for responding the questionnaire, which was based on this research. With the research scale, SIS(Sexual interest and satisfaction) by Siosteen et al.. (1990) and SB(Sexual behaviour) by Kreuter et al.(1996) were used for the measurement of sexual adjustment. And, for measuring quality of life was used SCI QL-23(Spinal cord injury of life-23) scale by Lundqvist et al. (1997). Data were collected from January 20 to March 20, 1999, using a structured questionnaire. A hundred volumes of questionnaire were used, and 85 volumes were collected, 70 volumes were used as research data after excluding 15 volumes unsuitable to data analysis. The obtain data were analysed using percentage, t-test. ANOVA. Duncan test, and Pearson's correlation by SAS PC+ program. The results were as follows: 1. The mean score of sexual interest and satisfaction of the subjects was 8.42, out of 18. The ways of their sexual behavior after spinal cord injuries were embracing and caressing (62.9%), kissing(58.6%), caressing breast with hands (55.7%), caressing breast with hands (52.9%), caressing genitals with hands (37.2%), caressing genitals with mouth(30.0%) and sexual intercourse (18.6%). The mean score of quality of life was 52.53 out of 100. 2. Age(F=3.24. p= .045) and caregiver (F=4.02. p=.022)were major variables which reveals significant differences in terms for sexual interest and satisfaction. The later results on Duncan's test showed that subjects who were in their 30s or 40s were significant higher than subjects whose age were in their 50s in their sexual interest and satisfaction. Also subjects with their spouse's care or mother's care were higher than those with other's care. 3. Subjects with incomplete paraplegia were higher than those with the complete paraplegia in sexual interest and satisfaction(F=3.01. p= .036). 4. Variables that showed the significant differences in the quality of life were education(t=2.860. p= .007) and period of marriage(t=2.125. p=.037). and occupational status(t=-2.161. p=.034). High school graduates. those who married before spinal cord injuries and those who didn't have occupation were higher than the other subjects. 5. Variables that revealed significant differences in the quality of life were time passage after spinal cord injuries(F=8.72. p=.001) and injured level of spinal cord(F=3.32. p= .042). Duncan's test showed that subjects who had lived for less than 4 years were higher those with time passage of 5-9 years and 10 years. Also subjects with lumbar injuries were higher than those with thoracic injuries in terms of quality of life. 6. There was negatively correlated between sexual interest and satisfaction and quality of life(r=- .256. p .05). As a result of these findings sexuality rehabilitation for individuals with SCI was very important issue for their quality of life. Thus, registered nurses who care clients with SCI should activily participate in the client's sexual needs. Also, various sexual behaviors as well as sexual intercourse should be encouraged for the sexual adjustment of client's with SCI.
Breast
;
Caregivers
;
Coitus
;
Gwangju
;
Hand
;
Humans
;
Jeollanam-do
;
Male
;
Occupations
;
Paraplegia
;
Quality of Life*
;
Surveys and Questionnaires
;
Rehabilitation
;
Rehabilitation Nursing
;
Seoul
;
Sexual Behavior
;
Sexuality
;
Spinal Cord Injuries*
;
Spinal Cord*
;
Statistics as Topic
;
Thoracic Injuries
2.Development of Desmoid and Mesenteric Fibromas following Total Colectomy for Adenomatous Polyposis Coli in Gardner's syndrome.
Korean Journal of Pathology 1989;23(4):465-469
We describe a case of polyposis coli, which was followed by development of desmoid in the rectus adbominis muscle and fibromas in the mesentery during an interval of two years. This case supports the hypothesis that, in Garder's syndrome, the traumatic injury by colectomy triggers an unusual fibrous proliferation in the peritoneal cavity and incision site under the possible genetic basis.
3.Diagnostic validity of the CES-D(Korean version) in the assessment of DSM-III-R major depression.
Journal of Korean Neuropsychiatric Association 1993;32(3):381-399
No abstract available.
Depression*
4.Isolation of Echovirus Serotype 25 from Patient with Hand , Foot and Mouth Disease in Pusan , 1998.
Young Hee KIM ; Kyung Soon CHO
Journal of the Korean Society for Microbiology 1999;34(2):157-162
Identification of virus is very importnant in aspects of preventive surveillance system of viral infection. The first isolation of echovirus serotype 25 from hand, foot and mouth disease was accomplished in Pusan, 1998. The authors determined some properties of this virus. Two cases of outbreak were confirmed from the stools of a 3 year-old girl and one 4 year-old boy suffering from hand, foot and mouth disease. Both occurred in April. The isolated viruses showed strong cytopathic effect on RD cells, also on HEp-2, and Vero cell lines after 3 days at 34'C, CO incubation. Isolated virus was identified as echovirus serotype 25 by neutralizing antibody test. Electron micrograph of negative-stained echovirus serotype 25 showed non-enveloped, isometric particle and about 30 nm in diameter.
Animals
;
Antibodies, Neutralizing
;
Busan*
;
Child, Preschool
;
Enterovirus B, Human*
;
Female
;
Foot*
;
Foot-and-Mouth Disease*
;
Hand*
;
Hand, Foot and Mouth Disease
;
Humans
;
Male
;
Vero Cells
6.CT findings of thoracic involvement of lymphoma.
Hee Jin KIM ; Kyu Ok CHOE ; Hee Kyung CHO
Journal of the Korean Radiological Society 1993;29(2):223-229
Chest CT scans of 70 patents with malignant lymphoma were reviewed to evaluate the thoacic manifestation of malignant lymphoma. Sixteen patients had Hodgkin's disease and 54 patients had non-Hodgkin's lymphoma. The thoracic involvement of malignant lymphoma was observed i 47 patients (67.1%) and 11 of these patients had Hodgkin's disease, and 36 had non-Hodgkin's lympoma. The most common finding was mediastinal lymphadenopathy and the most frequently involved sites were anterior mediastinal and paratracheal lymph nodes. Pulmonary parenchymal involvement was seen in 11 patients (15.7%), and CT scan showed thickening of bronchovascular bundle, parenchymal consolidation and nodules. Pleural effusion was seen in 18 patients (25.7%), however, without any evidence of parietal pleural thickening in all cases. Involvement of chest wall and breast was seen in two patient(2.9%). The data obtained through the current study showed no differences from those of previous reports, except the fact that there was no CT evidence of pleural thickening in patients who had pleural effusion.
Breast
;
Hodgkin Disease
;
Humans
;
Lymph Nodes
;
Lymphatic Diseases
;
Lymphoma*
;
Lymphoma, Non-Hodgkin
;
Pleural Effusion
;
Rabeprazole
;
Thoracic Wall
;
Tomography, X-Ray Computed
7.Overview of Roles for Non-cardiac Natriuretic Peptides: Roles in Neural, Endocrine and Immune Systmes.
Kyung Woo CHO ; Suhn Hee KIM ; Sung Joo KIM
Journal of Korean Society of Endocrinology 2000;15(6):760-778
No Abstract Available.
Natriuretic Peptides*
8.Combination Chemotherapy with VP - 16 , Ifosfamide , and Cisplatin ( VIP ) in the Advanced Non - Small Cell Lung Cancer.
Yong Seon CHO ; Si Young KIM ; Jeong Hee KIM ; Hwi Joong YOON ; Kyung Sam CHO
Journal of the Korean Cancer Association 2000;32(1):86-92
PURPOSE: We conducted a phase II study in previously untreated patients with unresectable stage IIIB or IV non-small cell lung cancer to evaluate the response rate and toxicity of the combination chemotherapy regimen of etoposide, ifosfamide and cisplatin. MATERIALS AND METHODS: From September 1993 to December 1996, twenty patients with advanced non-small cell lung cancer (stage IIIB 5 and IV 15) (squamous cell 8, adeno- carcinoma 12), were enrolled in this study. There were 13 (65%) males and 7 (35%) females, and median age of patients were 56 years (range: 34~66). Eighteen patients had performance status (ECOG) 0~1, two patients had performance status 2. Treatment was consisted of cisplatin (20 mg/m2 i.v., day 1~4), VP-16 (etoposide) (75 mg/m2 i.v., day 1~4), ifosfamide (1000 mg/m2 i.v., day 1~4) with mesna. This treatment was repeated every four weeks. RESULTS: The overall response rate was 25%. Complete response rate was 5% (1/20) and partial response rate was 20% (4/20). The median cycle of response was 4 (2~6) cycles. The median overall survival time was 28 weeks (9~98 weeks). The median time to progression was 10 weeks (3~50 weeks). Toxicities were evaluated by WHO criteria. Toxicity > GradeIII included: leukopenia 1.6%, thrombocytopenia 3.2%, nausea and vomiting 15%, alopecia 30%, stomatitis 10%. These toxicities were tolerable and reversible. CONCLUSION: VIP regimen was not superior to previous regimens for advanced non-small all lung cancer, and the toxicities were tolerable.
Alopecia
;
Carcinoma, Non-Small-Cell Lung
;
Cisplatin*
;
Drug Therapy, Combination*
;
Etoposide
;
Female
;
Humans
;
Ifosfamide*
;
Leukopenia
;
Lung Neoplasms
;
Male
;
Mesna
;
Nausea
;
Small Cell Lung Carcinoma*
;
Stomatitis
;
Thrombocytopenia
;
Vomiting
9.The p53 Mutation and DNA Ploidy in Human Metastatic Breast Cancer.
Seong Jin CHO ; Ae Ree KIM ; Nam Hee WON
Korean Journal of Pathology 1997;31(2):135-144
The p53 gene, one of the tumor suppressor genes, is believed to play an important role through mutation and overexpression in the progression of various human malignant tumors. To compare the p53 mutation status between the primary and metastatic lesions of breast cancers and to investigate the mutational pattern of p53, immunohistochemistry (IHC) and polymerase chain reaction and single strand conformational polymorphism (PCR-SSCP) were performed in 25 cases of breast cancers with paraffin embedded tissue. Mutant protein products or point mutation were detected through IHC or PCR-SSCP method. And flow cytometrical (FCM) analysis were performed in the same paraffin blocks to correlate the DNA ploidy and p53 mutation. The following results are summarized. 1. The detection of the p53 gene mutation and overexpression of the p53 protein were measured in 40% and 48%, respectively, in 25 primary tumors, either or both methods was detected in 64%. 2. A concordance rate of the p53 protein expression between the primary and metastatic lesions of 25 breast cancers was 100%, but the concordance rate of the p53 gene mutation was 72%. 3. The correlation between the p53 mutation and the DNA aneuploidy was not statistically significant (p=0.38) 4. A p53 mutation by IHC or PCR-SSCP was more frequently detected in grade III breast cancers than in grade I or II. 5. Among 5 to 9 exons of the p53 gene, exon 7 was the most frequent mutation spot in this study. 6. Additional mutation of the p53 gene was developed in the three metastatic lesions. With the above results it is suggested that the p53 protein overexpression by immunohistochemistry is not correlated with the p53 mutation by PCR-SSCP. The p53 mutation pattern between the primary and metastatic lesions are not idenitical and an additional point mutation can occur in the metastatic lesion. The DNA aneuploidy is more frequently detected in the cases with the p53 protein overexpression than in the p53 protein negative, but it is not statistically significant.
Aneuploidy
;
Breast Neoplasms*
;
Breast*
;
DNA*
;
Exons
;
Genes, p53
;
Genes, Tumor Suppressor
;
Humans*
;
Immunohistochemistry
;
Mutant Proteins
;
Paraffin
;
Ploidies*
;
Point Mutation
;
Polymerase Chain Reaction
10.The p53 Mutation and DNA Ploidy in Human Metastatic Breast Cancer.
Seong Jin CHO ; Ae Ree KIM ; Nam Hee WON
Korean Journal of Pathology 1997;31(2):135-144
The p53 gene, one of the tumor suppressor genes, is believed to play an important role through mutation and overexpression in the progression of various human malignant tumors. To compare the p53 mutation status between the primary and metastatic lesions of breast cancers and to investigate the mutational pattern of p53, immunohistochemistry (IHC) and polymerase chain reaction and single strand conformational polymorphism (PCR-SSCP) were performed in 25 cases of breast cancers with paraffin embedded tissue. Mutant protein products or point mutation were detected through IHC or PCR-SSCP method. And flow cytometrical (FCM) analysis were performed in the same paraffin blocks to correlate the DNA ploidy and p53 mutation. The following results are summarized. 1. The detection of the p53 gene mutation and overexpression of the p53 protein were measured in 40% and 48%, respectively, in 25 primary tumors, either or both methods was detected in 64%. 2. A concordance rate of the p53 protein expression between the primary and metastatic lesions of 25 breast cancers was 100%, but the concordance rate of the p53 gene mutation was 72%. 3. The correlation between the p53 mutation and the DNA aneuploidy was not statistically significant (p=0.38) 4. A p53 mutation by IHC or PCR-SSCP was more frequently detected in grade III breast cancers than in grade I or II. 5. Among 5 to 9 exons of the p53 gene, exon 7 was the most frequent mutation spot in this study. 6. Additional mutation of the p53 gene was developed in the three metastatic lesions. With the above results it is suggested that the p53 protein overexpression by immunohistochemistry is not correlated with the p53 mutation by PCR-SSCP. The p53 mutation pattern between the primary and metastatic lesions are not idenitical and an additional point mutation can occur in the metastatic lesion. The DNA aneuploidy is more frequently detected in the cases with the p53 protein overexpression than in the p53 protein negative, but it is not statistically significant.
Aneuploidy
;
Breast Neoplasms*
;
Breast*
;
DNA*
;
Exons
;
Genes, p53
;
Genes, Tumor Suppressor
;
Humans*
;
Immunohistochemistry
;
Mutant Proteins
;
Paraffin
;
Ploidies*
;
Point Mutation
;
Polymerase Chain Reaction